FORWARD PHARMA A/S's ticker is FWP and the CUSIP is 34986J105. A total of 20 filers reported holding FORWARD PHARMA A/S in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $6,180,000 | -59.8% | 2,848,003 | -31.9% | 0.06% | -60.5% |
Q4 2017 | $15,382,000 | -60.8% | 4,179,940 | -35.3% | 0.15% | -68.9% |
Q3 2017 | $39,232,000 | -69.7% | 6,463,265 | +1.6% | 0.49% | -66.9% |
Q2 2017 | $129,381,000 | +7.9% | 6,364,059 | +14.1% | 1.48% | +4.7% |
Q1 2017 | $119,927,000 | +49.0% | 5,575,407 | +3.9% | 1.41% | +34.5% |
Q4 2016 | $80,510,000 | -28.5% | 5,367,300 | 0.0% | 1.05% | -34.4% |
Q3 2016 | $112,660,000 | +15.5% | 5,367,300 | 0.0% | 1.60% | +20.9% |
Q2 2016 | $97,524,000 | +6.9% | 5,367,300 | 0.0% | 1.32% | +0.5% |
Q1 2016 | $91,244,000 | -10.5% | 5,367,300 | 0.0% | 1.32% | -28.8% |
Q4 2015 | $101,979,000 | -19.4% | 5,367,300 | 0.0% | 1.85% | -12.2% |
Q3 2015 | $126,454,000 | -38.1% | 5,367,300 | 0.0% | 2.11% | -38.1% |
Q2 2015 | $204,226,000 | +34.4% | 5,367,300 | 0.0% | 3.40% | +33.3% |
Q1 2015 | $152,002,000 | +36.0% | 5,367,300 | 0.0% | 2.55% | +16.3% |
Q4 2014 | $111,801,000 | – | 5,367,300 | – | 2.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,455,117 | $8,571,000 | 1.09% |
Baupost Group | 6,463,265 | $39,232,000 | 0.49% |
Newtyn Management, LLC | 268,903 | $1,584,000 | 0.26% |
Assured Investment Management LLC | 1,475,612 | $7,383,000 | 0.15% |
Freedom Investment Management, Inc. | 76,867 | $467,000 | 0.03% |
NJ State Employees Deferred Compensation Plan | 10,000 | $59,000 | 0.01% |
TWO SIGMA SECURITIES, LLC | 14,331 | $84,000 | 0.01% |
HIGHLAND CAPITAL MANAGEMENT LP | 17,000 | $100,000 | 0.00% |
ALPS ADVISORS INC | 46,468 | $274,000 | 0.00% |
Renaissance Technologies | 181,900 | $1,104,000 | 0.00% |